These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17632890)

  • 21. Paying for expensive medicines. Oncologists and top-ups.
    Warren VJ
    BMJ; 2009 Jun; 338():b2530. PubMed ID: 19549660
    [No Abstract]   [Full Text] [Related]  

  • 22. Reforming the cancer drug fund.
    Buxton M; Longworth L; Raftery J; Sculpher M; Towse A
    BMJ; 2014 Nov; 349():g7276. PubMed ID: 25432928
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention, survivorship highlighted in England's cancer plan update.
    Travis K
    J Natl Cancer Inst; 2008 Apr; 100(7):454-5. PubMed ID: 18364496
    [No Abstract]   [Full Text] [Related]  

  • 24. National cancer director responds on top-up payments.
    Richards M
    BMJ; 2008 Jul; 337(7661):a686. PubMed ID: 18614496
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs are scarce as mix of programs aims to ease access.
    Brower V
    J Natl Cancer Inst; 2009 Oct; 101(19):1304-6. PubMed ID: 19755680
    [No Abstract]   [Full Text] [Related]  

  • 26. Paying for modern cancer care--a global perspective.
    Rawlins M
    Lancet Oncol; 2007 Sep; 8(9):749-51. PubMed ID: 17765184
    [No Abstract]   [Full Text] [Related]  

  • 27. Outpatient cancer drug costs: changes, drivers, and the future.
    Halbert RJ; Zaher C; Wade S; Malin J; Lawless GD; Dubois RW
    Cancer; 2002 Feb; 94(4):1142-50. PubMed ID: 11920485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival of cancer patients in Finland, 1955-1994.
    Coebergh JW
    Acta Oncol; 1999; 38(5):531-3. PubMed ID: 10427940
    [No Abstract]   [Full Text] [Related]  

  • 29. High cancer drug prices in the United States: reasons and proposed solutions.
    Kantarjian H; Steensma D; Rius Sanjuan J; Elshaug A; Light D
    J Oncol Pract; 2014 Jul; 10(4):e208-11. PubMed ID: 24803662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Top-up insurance for cancer drugs.
    Sikora K
    Br J Hosp Med (Lond); 2007 Jun; 68(6):288-9. PubMed ID: 17639822
    [No Abstract]   [Full Text] [Related]  

  • 31. Placing bets on biotech.
    Weintraub K
    Cancer Discov; 2011 Nov; 1(6):462. PubMed ID: 22586641
    [No Abstract]   [Full Text] [Related]  

  • 32. Inequalities in oncology care: Economic consequences of high cost drugs.
    Niezen MG; Stolk EA; Steenhoek A; Uyl-De Groot CA
    Eur J Cancer; 2006 Nov; 42(17):2887-92. PubMed ID: 16979891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Follow-up studies of tumor patients: what is reasonable today?].
    Sauter C
    Ther Umsch; 1988 Jun; 45(6):393-6. PubMed ID: 2457958
    [No Abstract]   [Full Text] [Related]  

  • 34. The economic burden of anemia in cancer patients receiving chemotherapy.
    Lyman GH; Berndt ER; Kallich JD; Erder MH; Crown WH; Long SR; Lee H; Song X; Finkelstein SN
    Value Health; 2005; 8(2):149-56. PubMed ID: 15804323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why not adopt the blacklist of yore?
    Lewis LS
    BMJ; 2008 Jul; 337(7662):a807. PubMed ID: 18625603
    [No Abstract]   [Full Text] [Related]  

  • 36. Value and payment for oncology in the United States.
    Robinson JC
    Ann Pharm Fr; 2013 Sep; 71(5):285-90. PubMed ID: 24075699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "To the heart of the matter...".
    Kamen BA; Drachtman R
    Pediatr Hematol Oncol; 2000; 17(1):5-7. PubMed ID: 10689709
    [No Abstract]   [Full Text] [Related]  

  • 38. Does evidence-based medicine really reduce costs?
    Kolodziej MA
    Oncology (Williston Park); 2011 Mar; 25(3):214, 218. PubMed ID: 21548463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why managed care should provide supportive therapies for cancer patients.
    Rubenstein SA
    Manag Care; 1995 Aug; 4(8):37-9. PubMed ID: 10145013
    [No Abstract]   [Full Text] [Related]  

  • 40. Conservatism and the cancer drugs fund.
    Hopkinson NS
    BMJ; 2017 May; 357():j2451. PubMed ID: 28539426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.